Adagene (ADAG)
(Delayed Data from NSDQ)
$2.37 USD
+0.47 (24.79%)
Updated Aug 6, 2025 04:00 PM ET
After-Market: $2.43 +0.06 (2.53%) 4:44 PM ET
3-Hold of 5 3
F Value F Growth C Momentum F VGM
Fundamental Charts
About Market Cap
As of the previous market close, Adagene Inc. Sponsored ADR has a market cap of $89.47M, which represents its share price of $1.90 multiplied by its outstanding shares number of 47.11M. As a small-cap company, ADAG's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
ADAG 2.37 +0.47(24.79%)
Will ADAG be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for ADAG based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ADAG
Is McKesson (MCK) Outperforming Other Medical Stocks This Year?
Is Adagene (ADAG) Stock Outpacing Its Medical Peers This Year?
ADAG: What are Zacks experts saying now?
Zacks Private Portfolio Services
Is Bioventus (BVS) Outperforming Other Medical Stocks This Year?
Are Medical Stocks Lagging Adagene (ADAG) This Year?
Is Adagene (ADAG) Stock Outpacing Its Medical Peers This Year?
Other News for ADAG
Adagene (ADAG) Coverage Initiated by Leerink Partners with $7 PT | ADAG Stock News
This Palvella Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
Adagene (ADAG) Receives Outperform Rating from Leerink
Adagene initiated with bullish view at Leerink, here's why
Adagene Announces Regulatory Update on Clinical Development Plan for Muzastotug in ...